Literature DB >> 33925486

Associations of Dietary ω-3, ω-6 Fatty Acids Consumption with Sleep Disorders and Sleep Duration among Adults.

Jia Luo1, Honghan Ge1, Jing Sun1, Kangyu Hao1, Wenqin Yao1, Dongfeng Zhang1.   

Abstract

The relationship between ω-3 and ω-6 fatty acids consumption and sleep disorders or duration are controversial. Therefore, we used the data of the National Health and Nutrition Examination Survey 2007-2016 in this cross-sectional study to explore their relationships. ω-3 and ω-6 fatty acids consumption was assessed using two 24 h dietary recall interviews. Sleep disorders and sleep duration were based on self-reported data. Logistic regression models and restricted cubic spline analyses were used. Compared with tertile one, the odds ratios (ORs) and 95% confidence intervals (CIs) of sleep disorders for the second tertile of ω-6 fatty acid intake and the highest tertile of ω-6:ω-3 ratio were 1.30 (1.04-1.62) and 1.36 (1.08-1.70), respectively. Inverse U-shaped and linear dose-response relationships were observed between dietary ω-6 fatty acid intake and ω-6:ω-3 ratio and sleep disorders, respectively. In addition, ω-3 fatty acid consumption was adversely related to sleep disorders in men and the OR (95% CI) was 0.68 (0.49-0.95). Compared with normal sleep duration, ω-3 fatty acid consumption was negatively related to very short, short, and long sleep duration risk. The relative risk ratios (RRRs) were 0.53 (0.35-0.81), 0.79 (0.67-0.93), and 0.81 (068-0.98), respectively. The RRR of very short sleep for ω-6 fatty acid consumption was 0.57 (0.45-0.73). Our study indicates that ω-6 fatty acid consumption and the ω-6:ω-3 ratio are positively associated with the risk of sleep disorders, while the negative association between ω-3 fatty acids and sleep disorders may exist only in men. Furthermore, ω-3 and ω-6 fatty acid consumption are negatively related to the risk of non-normal sleep duration.

Entities:  

Keywords:  dietary ω-3 fatty acids; dietary ω-6 fatty acids; dose–response relationship; sleep disorders; sleep duration

Year:  2021        PMID: 33925486     DOI: 10.3390/nu13051475

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  60 in total

Review 1.  Sleep and emotional processing.

Authors:  Daniela Tempesta; Valentina Socci; Luigi De Gennaro; Michele Ferrara
Journal:  Sleep Med Rev       Date:  2017-12-22       Impact factor: 11.609

Review 2.  Sleep loss, learning capacity and academic performance.

Authors:  Giuseppe Curcio; Michele Ferrara; Luigi De Gennaro
Journal:  Sleep Med Rev       Date:  2006-03-24       Impact factor: 11.609

Review 3.  Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits.

Authors:  Fereidoon Shahidi; Priyatharini Ambigaipalan
Journal:  Annu Rev Food Sci Technol       Date:  2018-03-25

4.  Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients.

Authors:  B Guarnieri; F Adorni; M Musicco; I Appollonio; E Bonanni; P Caffarra; C Caltagirone; G Cerroni; L Concari; F I I Cosentino; S Ferrara; S Fermi; R Ferri; G Gelosa; G Lombardi; D Mazzei; S Mearelli; E Morrone; L Murri; F M Nobili; S Passero; R Perri; R Rocchi; P Sucapane; G Tognoni; S Zabberoni; S Sorbi
Journal:  Dement Geriatr Cogn Disord       Date:  2012-03-08       Impact factor: 2.959

5.  A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.

Authors:  Catherine Cornu; Laurent Remontet; Florence Noel-Baron; Alain Nicolas; Nathalie Feugier-Favier; Pascal Roy; Bruno Claustrat; Mitra Saadatian-Elahi; Behrouz Kassaï
Journal:  BMC Complement Altern Med       Date:  2010-06-22       Impact factor: 3.659

6.  Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Ka He; Kiang Liu; Martha L Daviglus; Nancy Swords Jenny; Elizabeth Mayer-Davis; Rui Jiang; Lyn Steffen; David Siscovick; Michael Tsai; David Herrington
Journal:  Am J Cardiol       Date:  2009-03-04       Impact factor: 2.778

7.  Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.

Authors:  Lee S Cohen; Hadine Joffe; Katherine A Guthrie; Kristine E Ensrud; Marlene Freeman; Janet S Carpenter; Lee A Learman; Katherine M Newton; Susan D Reed; Joann E Manson; Barbara Sternfeld; Bette Caan; Ellen W Freeman; Andrea Z LaCroix; Lesley F Tinker; Cathryn Booth-Laforce; Joseph C Larson; Garnet L Anderson
Journal:  Menopause       Date:  2014-04       Impact factor: 2.953

Review 8.  Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.

Authors:  Luciano F Drager; R Doug McEvoy; Ferran Barbe; Geraldo Lorenzi-Filho; Susan Redline
Journal:  Circulation       Date:  2017-11-07       Impact factor: 29.690

9.  Gender Differences in the Associations of Plasma Pyridoxal 5'-Phosphate with Plasma Polyunsaturated Fatty Acids among US Young and Middle-Aged Adults: NHANES 2003-2004.

Authors:  Hyojung Kim; Evelyn B Enrione; Vijaya Narayanan; Tan Li; Adriana Campa
Journal:  Nutrients       Date:  2021-01-31       Impact factor: 5.717

10.  Health implications of high dietary omega-6 polyunsaturated Fatty acids.

Authors:  E Patterson; R Wall; G F Fitzgerald; R P Ross; C Stanton
Journal:  J Nutr Metab       Date:  2012-04-05
View more
  2 in total

1.  Associations of α-linolenic acid dietary intake with very short sleep duration in adults.

Authors:  Qianning Liu; Qingsong Shan
Journal:  Front Public Health       Date:  2022-08-18

2.  Association of Pyridoxal 5'-Phosphate with Sleep-Related Problems in a General Population.

Authors:  Lin Ge; Jia Luo; Liming Zhang; Xiao Kang; Dongfeng Zhang
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.